Jean Grégoire

4.9k total citations
22 papers, 929 citations indexed

About

Jean Grégoire is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jean Grégoire has authored 22 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jean Grégoire's work include Cardiac Imaging and Diagnostics (9 papers), Lipoproteins and Cardiovascular Health (9 papers) and Coronary Interventions and Diagnostics (7 papers). Jean Grégoire is often cited by papers focused on Cardiac Imaging and Diagnostics (9 papers), Lipoproteins and Cardiovascular Health (9 papers) and Coronary Interventions and Diagnostics (7 papers). Jean Grégoire collaborates with scholars based in Canada, United States and Switzerland. Jean Grégoire's co-authors include Jean‐Claude Tardif, Philippe L. L’Allier, Jacques Lespérance, Lawrence Title, François Reeves, André Arsenault, Todd J. Anderson, Réda Ibrahim, Pierre Théroux and Marie‐Claude Guertin and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

Jean Grégoire

22 papers receiving 884 citations

Peers

Jean Grégoire
Young Won Yoon South Korea
Kee‐Sik Kim South Korea
Sion Roy United States
Yin Zhang China
Jean Grégoire
Citations per year, relative to Jean Grégoire Jean Grégoire (= 1×) peers Sandrin C. Bergheanu

Countries citing papers authored by Jean Grégoire

Since Specialization
Citations

This map shows the geographic impact of Jean Grégoire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Grégoire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Grégoire more than expected).

Fields of papers citing papers by Jean Grégoire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Grégoire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Grégoire. The network helps show where Jean Grégoire may publish in the future.

Co-authorship network of co-authors of Jean Grégoire

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Grégoire. A scholar is included among the top collaborators of Jean Grégoire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Grégoire. Jean Grégoire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
AlTurki, Ahmed, Marie‐Pierre Dubé, Lucy Vieira, et al.. (2019). Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes. The American Journal of Cardiology. 124(12). 1869–1875. 17 indexed citations
2.
Gebhard, Cathérine, David Rhainds, Gang He, et al.. (2018). Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden. Atherosclerosis. 276. 131–139. 16 indexed citations
3.
Turgeon, Ricky D., Todd J. Anderson, Jean Grégoire, & Glen J. Pearson. (2017). 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 150(4). 243–250. 7 indexed citations
4.
Fitchett, David, Shaun G. Goodman, Lawrence A. Leiter, et al.. (2016). Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations. Canadian Journal of Cardiology. 32(7). S15–S34. 8 indexed citations
5.
Anderson, Todd J., G.B. John Mancini, Jacques Genest, et al.. (2014). The New Dyslipidemia Guidelines: What Is the Debate?. Canadian Journal of Cardiology. 31(5). 605–612. 48 indexed citations
6.
Berry, Colin, Stéphane Noble, Réda Ibrahim, et al.. (2010). Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease. American Heart Journal. 160(1). 188–194.e1. 2 indexed citations
7.
Tardif, Jean‐Claude, Philippe L. L’Allier, Jean Grégoire, et al.. (2010). A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions. 3(6). 543–548. 57 indexed citations
8.
Rodés‐Cabau, Josep, Jean‐Claude Tardif, Mariève Cossette, et al.. (2009). Acute Effects of Statin Therapy on Coronary Atherosclerosis Following an Acute Coronary Syndrome. The American Journal of Cardiology. 104(6). 750–757. 17 indexed citations
9.
Tardif, Jean‐Claude, Jean Grégoire, Philippe L. L’Allier, et al.. (2007). Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Atherosclerosis. 197(1). 480–486. 61 indexed citations
10.
Tardif, Jean‐Claude, Jean Grégoire, Philippe L. L’Allier, et al.. (2006). Effect of Atherosclerotic Regression on Total Luminal Size of Coronary Arteries as Determined by Intravascular Ultrasound. The American Journal of Cardiology. 98(1). 23–27. 19 indexed citations
11.
Guédès, Antoine, Pierre‐Frédéric Keller, Philippe L. L’Allier, et al.. (2005). Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. Journal of the American College of Cardiology. 45(4). 559–564. 37 indexed citations
12.
Tardif, Jean‐Claude, Jean Grégoire, Marc-André Lavoie, & Philippe L. L’Allier. (2003). Vascular protectants for the treatment of atherosclerosis. Expert Review of Cardiovascular Therapy. 1(3). 385–392. 13 indexed citations
13.
Tardif, Jean‐Claude, Jean Grégoire, Leonard Schwartz, et al.. (2003). Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions. Circulation. 107(4). 552–558. 143 indexed citations
14.
L’Allier, Philippe L., Jean Grégoire, Michel Joyal, & Jean‐Claude Tardif. (2002). Persistently elevated levels of soluble CD40 ligand one month after percutaneous coronary angioplasty correlate with six-month restenosis. Journal of the American College of Cardiology. 39. 32–32. 2 indexed citations
15.
Tardif, Jean‐Claude, Jean Grégoire, Jacques Lespérance, et al.. (2002). Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial. American Heart Journal. 144(4). 589–596. 33 indexed citations
16.
Giannetti, Nadia, Martin Juneau, André Arsenault, et al.. (1999). Sauna-induced myocardial ischemia in patients with coronary artery disease. The American Journal of Medicine. 107(3). 228–233. 44 indexed citations
17.
Grégoire, Jean & André Duranceau. (1992). Surgical management of Zenker's diverticulum.. PubMed. 39(2). 132–8. 27 indexed citations
18.
Bilodeau, Luc, Pierre Théroux, Jean Grégoire, David Gagnon, & André Arsenault. (1991). Technetium-99m sestamibi tomography in patients with spontaneous chest pain: Correlations with clinical, electrocardiographic and angiographic findings. Journal of the American College of Cardiology. 18(7). 1684–1691. 104 indexed citations
19.
Grégoire, Jean & Pierre Théroux. (1990). Detection and assessment of unstable angina using myocardial perfusion imaging: Comparison between technetium-99m sestamibi SPECT and 12-lead electrocardiogram. The American Journal of Cardiology. 66(13). E42–E46. 39 indexed citations
20.
Grégoire, Jean, et al.. (1980). [Treatment of sleep disorders with zopiclone. Clinical trials using a double-blind method versus placebo].. PubMed. 34(3). 317–25. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026